Or how about the drug companies? Holy cow, remember them? They used to be big and important, weren’t they? Eli Lilly reported ...
Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price target for Eli Lilly & ...
Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production ...
In today’s ACT Brief, we explore how Eli Lilly’s orforglipron could become the first oral GLP-1 therapy reviewed under FDA’s new national priority program, and examine emerging regulatory and ethical ...
The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...
Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be reporting results this Tuesday after market close. Here’s what ...
South Korean tech giant Samsung is making a major investment in artificial intelligence by building a factory powered by 50,000 Nvidia GPUs. This AI megafactory, as Samsung calls it, aims to ...
Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central ...
Money on MSN
Here Are the Stocks AI Likes for November
AI use cases now run the gamut. From early cancer detection and digital companionship to helping frustrated readers find ...
Lending platform Pagaya Technologies on Monday announced an agreement to sell up... The owners of the distribution firm behind Irish fake tan brands such as Suzanne... Grant Thornton’s non-audit ...
Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...
Pfizer filed an antitrust lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for biotech Metsera to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback